[
  {
    "ts": null,
    "headline": "Sage Therapeutics: Biogen's Unsolicited Bid Is Best Step Forward For Shareholders",
    "summary": "Analysis of Sage Therapeutics' financials and pipeline setbacks, including an unsolicited offer from Biogen, suggest a hold for investors. Click here to read.",
    "url": "https://finnhub.io/api/news?id=f93f44fdf6d98e179461e3cae3dd2b1803eefd1088a5971b06fe5af2990079ec",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736936448,
      "headline": "Sage Therapeutics: Biogen's Unsolicited Bid Is Best Step Forward For Shareholders",
      "id": 132400081,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2184874810/image_2184874810.jpg?io=getty-c-w1536",
      "related": "BIIB",
      "source": "SeekingAlpha",
      "summary": "Analysis of Sage Therapeutics' financials and pipeline setbacks, including an unsolicited offer from Biogen, suggest a hold for investors. Click here to read.",
      "url": "https://finnhub.io/api/news?id=f93f44fdf6d98e179461e3cae3dd2b1803eefd1088a5971b06fe5af2990079ec"
    }
  },
  {
    "ts": null,
    "headline": "Biogen Inc. (BIIB) J.P. Morgan 43rd Annual Healthcare Conference (Transcript)",
    "summary": "Biogen Inc. (NASDAQ:BIIB) J.P.",
    "url": "https://finnhub.io/api/news?id=596b44a0dfff80eec18afee169ca3a8d7c0759ce5f82988b3c98500c72939086",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736932816,
      "headline": "Biogen Inc. (BIIB) J.P. Morgan 43rd Annual Healthcare Conference (Transcript)",
      "id": 132399970,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "BIIB",
      "source": "SeekingAlpha",
      "summary": "Biogen Inc. (NASDAQ:BIIB) J.P.",
      "url": "https://finnhub.io/api/news?id=596b44a0dfff80eec18afee169ca3a8d7c0759ce5f82988b3c98500c72939086"
    }
  }
]